Has Jason Ahuero, MD received payments from drug or device companies?

Yes. Drug and device makers reported $35,400 in general payments to Jason Ahuero, MD across 201 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jason Ahuero, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jason Ahuero, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jason Ahuero, MD

Foot and Ankle Surgery · Houston, TXNPI 1518176338

Payments from drug & device makers

What this record shows

The money is spread across several categories — other (44.2%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 23 manufacturers reported payments, led by Linvatec Corporation at 44.5% of the total. Reporting peaked in 2022 at $16,229 and has fallen 60.8% since, to $6,357 in 2025. Among foot and ankle surgery clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$35,400in general payments, 2019–2025

Across 201 payments — averaging $176.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Linvatec Corporation$16K
Medinc Of Texas$7K
Arthrex$6K
Stryker$2K
Alafair Biosciences, Inc.$948
Paragon 28, Inc.$672
plus $3K from 17 others

$40,407in research payments, 2019–2025

Across 4 payments — averaging $10,102 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Novartis$40K

What the payments were for

Speaking & faculty fees$4,75013%
Travel & lodging$4,80914%
Food & beverage$6,87319%
Education$3,3199%
Other$15,64944%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Linvatec Corporation	6	$15,749
Medinc Of Texas	23	$6,662
Arthrex	36	$6,478
Stryker	34	$2,295
Alafair Biosciences, Inc.	6	$948
Paragon 28, Inc.	7	$672
Pylant Medical	2	$464
Treace Medical Concepts, Inc.	6	$430
Ortho Solutions Inc	4	$418
Ossur Americas, Inc.	48	$362
Bioventus LLC	7	$168
Smith+Nephew	6	$168
Osteomed LLC	1	$130
Voom Medical Devices, Inc.	1	$89
Medshape, Inc.	1	$69
Acera Surgical, Inc.	2	$64
Kerecis Limited	2	$50
Integra Lifesciences Corporation	3	$47
ERMI LLC	2	$44
Acumed LLC	1	$42
Vertex	1	$20
Orthofix Medical, Inc.	1	$20
Johnson & Johnson	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

AVENGER RADIAL HEAD, +4 STEMS$15,558
VersaWrap$787
INFINITY ADAPTIS$412
Lapiplasty System$295
APEX 3D$245
INBONE$212
ACCOLADE$173
GAMMA$173
HOFFMANN$173
T2$173
AXSOS$173
Actishield$151
PROSTEP MICA$147
EASYFUSE$147
EXT-ExtremiLock Ankle$130
AUGMENT INJECTABLE$126
DISTAL EXTREMITIES INSTRUMENTS PERCUTANEOUS FOOT SURGERY SU BURRS$125
GORILLA$116

How this compares

$35,400 in reported general payments places this provider in the 90th percentile of 684 foot and ankle surgery providers in Texas.

See all foot and ankle surgery providers in Texas →

Medicare billing

Part B allowed, 2024

$149,954

Medicare patients

329

Services billed

2,528

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	99	$899
Celecoxib	22	$770
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	42	$323
Gabapentin	26	$259
Cephalexin	97	$148
Meloxicam	27	$142
Ondansetron OdtOndansetron	27	$118
Acetaminophen-CodeineAcetaminophen With Codeine	19	$109
Ondansetron Hcl	39	$99
Doxycycline Hyclate	14	$81
Tramadol Hcl	27	$64

Paid to pharmacies, not to this prescriber.

Other foot and ankle surgery in Houston

Kevin VarnerHouston$1.1M
Sherman NaglerHouston$602K
Abdul NurudeenHouston$404K
Orlando RiveraHouston$384K
Brian LepowHouston$309K
Yueh LeeHouston$95K
William GranberryHouston$84K
Nathaniel AlabiHouston$71K
Jorge MatukHouston$45K
William McGarveyKaty$3.5M

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →